Zobrazeno 1 - 4
of 4
pro vyhledávání: '"William C. Waterfield"'
Autor:
Ross C. Donehower, William C. Waterfield, Nancy E. Davidson, Gary G. Gordon, Roy A. Beveridge, Dorothy J. Damron, John H. Fetting, Martin D. Abeloff
Publikováno v:
JNCI Journal of the National Cancer Institute. 82:570-574
Fifty-three women with breast cancer were treated with a new 16-week dose-intense, chemotherapy regimen. Patients with operable breast cancer with 10 or more histologically positive axillary nodes were treated with this five-drug regimen that incorpo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f07f6b669b1e3dd94618ef877d037fd
https://doi.org/10.1093/jnci/82.7.570
https://doi.org/10.1093/jnci/82.7.570
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(2)
PURPOSE: Although physicians view failure to assess pain systematically as the most important barrier to outpatient cancer pain management, little is known about pain assessment in this setting. We sought to determine whether pain is routinely assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7725a061bcf9c0546f04eaf8ac617864
https://pubmed.ncbi.nlm.nih.gov/11208844
https://pubmed.ncbi.nlm.nih.gov/11208844
Publikováno v:
The American Journal of dermatopathology. 18(1)
A 55-year-old woman had a history of prolonged vaginal bleeding. Dilatation and curettage confirmed poorly differentiated endometrial adenocarcinoma. After hysterectomy, salpingo-oophorectomy, and 5,040 cGy of postoperative irradiation, lung metastas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e64f426a3853e17fe5c5e4a582a5ca8
https://pubmed.ncbi.nlm.nih.gov/8721599
https://pubmed.ncbi.nlm.nih.gov/8721599
Autor:
Aman U. Buzdar, Charles K. Tashima, Gabriel N. Hortobagyi, George R. Blumenschein, Michael A. Burgess, William C. Waterfield
Publikováno v:
Cancer. 41:1235-1239
Adriamycin every three weeks and CCNU every six weeks were given to thirty patients with metastatic breast carcinoma. Most patients had received prior chemotherapy. The overall response rate was 40%, with three patients obtaining complete remission.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b77e55e053e48dcc58f9a81049462406
https://doi.org/10.1002/1097-0142(197804)41:4<1235::aid-cncr2820410403>3.0.co
https://doi.org/10.1002/1097-0142(197804)41:4<1235::aid-cncr2820410403>3.0.co